Skip to main content
IMUGENE LIMITED logo

IMUGENE LIMITED — Investor Relations & Filings

Ticker · IMU ISIN · AU000000IMU9 LEI · 984500A5C9KF08EAF248 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,444 across all filing types
Latest filing 2005-01-30 Capital/Financing Update
Country AU Australia
Listing ASX IMU

About IMUGENE LIMITED

https://imugene.com

Imugene Limited is a clinical-stage immuno-oncology company focused on developing immunotherapies to activate the immune system against various cancers. The company’s pipeline features multiple platform technologies, including B-cell activating immunotherapies, oncolytic viruses, and CAR-T cell enhancement therapies. Key clinical candidates include HER-Vaxx, targeting HER2-positive gastric cancer, and PD1-Vaxx, a checkpoint inhibitor immunotherapy. Imugene is also advancing the CF33 oncolytic virus platform, which includes VAXINIA and CHECKvacc, alongside the onCARlytics program. The onCARlytics platform is designed to enable CAR-T cells to target solid tumors by inducing the expression of CD19 on cancer cell surfaces. These programs aim to address unmet needs in oncology by providing targeted, potent, and potentially less toxic alternatives to conventional treatments.

Recent filings

Filing Released Lang Actions
Appendix 3B - Issue of Performance Options 8 pages ?Kb
Capital/Financing Update Classification · 100% confidence The document is an Appendix 3B form, which is a standard Australian Securities Exchange (ASX) announcement used to notify the market of a new issue of securities, application for quotation of additional securities, and related agreements. It details the class and number of securities issued, terms of the securities, issue price, purpose of the issue, and other related information. This type of document is a capital/financing update rather than a full financial report or earnings release. It is not an annual report, interim report, or earnings release, nor is it a regulatory filing or announcement of voting results. The document is lengthy (15,000 characters) and contains substantive information about securities issuance and quotation application, fitting the Capital/Financing Update category (CAP).
2005-01-30 English
Commitments Test Entity - Second Quarter Report 5 pages ?Kb
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Appendix 4C' and is described as a 'Quarterly report for entities admitted on the basis of commitments.' It contains detailed financial data including consolidated cash flow statements for the quarter ended 31 December 2004, with line items for operating, investing, and financing activities. It also includes payments to directors, financing facilities, reconciliation of cash, and compliance statements. The presence of substantive financial data and the quarterly period covered indicate this is a comprehensive interim financial report rather than a brief announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2005-01-26 English
Appendix 3B-Working Capital/Section 708A Notice 9 pages ?Kb
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B' and is a 'New issue announcement, application for quotation of additional securities and agreement' submitted to the ASX (Australian Securities Exchange). It details the issuance of new ordinary shares and options, including the number of securities, issue price, purpose of the issue, and dates related to the securities. This type of document is a formal announcement related to capital raising and issuance of new securities, which aligns with the category of Capital/Financing Update (CAP). It is not a full financial report, audit, or earnings release, but rather a specific announcement about new securities issuance and related capital activities.
2005-01-20 English
Finalisation of $5m Share Placement 2 pages ?Kb
Capital/Financing Update Classification · 100% confidence The document is an ASX announcement dated 21 January 2005 regarding the finalisation of a $5 million share placement by Imugene. It details the number of shares and options issued, the price, and the investors involved. The content focuses on fundraising and capital structure changes, with no financial statements or detailed financial performance data. The document length is 2459 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this fits the definition of a Capital/Financing Update (CAP).
2005-01-20 English
Imugene Receptor Mimic Technology Patent Granted in US 2 pages ?Kb
Regulatory Filings Classification · 90% confidence The document is an ASX announcement dated 17 January 2005 about Imugene being granted a patent for its Receptor Mimic Technology in the United States. It discusses the significance of the patent for the company's products and markets but does not contain any financial statements, detailed financial performance data, or regulatory filings. The document is relatively short (3249 characters) and serves as a news announcement about a patent grant rather than a financial report or regulatory filing. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is an announcement of a significant corporate development related to intellectual property. Therefore, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous announcements that do not fit other categories.
2005-01-16 English
Becoming a substantial holder 2 pages ?Kb
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 Notice of Initial Substantial Holder filed under the Corporations Act 2001. It details the acquisition of a substantial shareholding in a company, including voting power, relevant interests, registered holders, and consideration paid. This type of filing is a notification of a major shareholding change, not a financial report, management announcement, or other corporate filing. It matches the description of Major Shareholding Notification filings, which report changes in significant share ownership levels crossing thresholds.
2005-01-12 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.